News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wysenski Nancy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 224 shares
@ $27.88, valued at
$6.2k
|
|
| 07/10/2023 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 1,430 shares
@ $29.88, valued at
$42.7k
Exercised 5,957 options to buy
@ $0 |
|
| 07/05/2023 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 187 shares
@ $33.36, valued at
$6.2k
|
|
| 06/30/2023 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 12,732 options to buy
@ $31.33, valued at
$398.9k
Granted 5,985 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $37.89, valued at
$378.9k
|
|
| 05/10/2023 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 41,250 shares
@ $31.2433, valued at
$1.3M
Exercised 35,000 options to buy
@ $31.13, valued at
$1.1M
Exercised 6,250 options to buy
@ $31.13, valued at
$194.6k
|
|
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 149 shares
@ $37.71, valued at
$5.6k
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 110 shares
@ $51.11, valued at
$5.6k
|
|
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 5,957 options to buy
@ $0
Granted 11,554 options to buy
@ $31.48, valued at
$363.7k
|
|
| 06/16/2022 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 695 shares
@ $27.19, valued at
$18.9k
Exercised 7,585 options to buy
@ $0 |
|
| 05/18/2022 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 33,000 options to buy
@ $4.52, valued at
$149.2k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 146 shares
@ $38.38, valued at
$5.6k
|
|
| 01/04/2022 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 122 shares
@ $46, valued at
$5.6k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2021 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 153 shares
@ $36.74, valued at
$5.6k
|
|
| 07/08/2021 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 31 shares
@ $19.77, valued at
$612.9 |
|
| 07/06/2021 |
3/A
| Wysenski Nancy (Director) has filed a Form 3/A on CYTOKINETICS INC |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 11,509 options to buy
@ $18.82, valued at
$216.6k
Granted 5,578 options to buy
@ $0 |
|
| 11/20/2020 |
4
| Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 35,000 options to buy
@ $15.99, valued at
$559.7k
|
|
| 11/20/2020 |
3
| Wysenski Nancy (Director) has filed a Form 3 on CYTOKINETICS INC |
| 07/16/2020 |
4
| Wysenski Nancy (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 22,200 options to buy
@ $12.62, valued at
$280.2k
|
|
|
|
|